Company Filing History:
Years Active: 2011-2015
Title: Keishi Okamoto: Innovator in Implant Materials
Introduction
Keishi Okamoto, an accomplished inventor based in Hiroshima, Japan, has made significant contributions to the field of implant materials. With a total of six patents, Okamoto is recognized for his innovative approach to enhancing the functionality and biocompatibility of medical implants.
Latest Patents
One of Okamoto's latest inventions is a unique implant material that includes a base material and a carbonaceous film applied to its surface. This carbonaceous film is composed of carbon, oxygen, and nitrogen atoms. Notably, the content of nitrogen atoms in the film is maintained at a minimum of 8.0 atomic percent, while carbon with a single bond to oxygen comprises at least 5.4 percent of the film. Furthermore, carboxyl carbon content is restricted to a maximum of 3.1 percent. The innovative method for manufacturing this implant material involves preparing the base material, removing moisture from the processing chamber, and then introducing material gas, which serves as both a carbon and silicon source, to form a carbon thin film via ionized deposition.
Career Highlights
Throughout his career, Keishi Okamoto has worked with renowned companies, including Toyo Advanced Technologies Co., Ltd. and Japan Stent Technology Co., Ltd. His dedication to research and development has propelled advancements in medical technology, particularly in the creation of safer and more effective implants.
Collaborations
Okamoto’s journey in innovation has been enriched by collaborations with notable coworkers such as Tatsuyuki Nakatani and Yuki Nitta. Their collective expertise has fostered a dynamic environment for the development of groundbreaking technologies in the medical field.
Conclusion
Keishi Okamoto stands out as a pioneering inventor whose work in implant materials not only enhances medical practices but also demonstrates the essential connection between innovation and healthcare advancements. His patents reflect a commitment to improving patient outcomes through scientific progress and collaboration within the industry.